Future Price to Earnings: CeriBell EEG (CBLL)
CeriBell, Inc. (CBLL) maintains a stable operational backdrop supported by the neutral status of biomedicine, which minimizes the impact of global conflicts. The business relies on the development of diagnostic solutions for the nervous system. Service scalability is ensured through outsourced EEG system production and cloud data storage. This price chart with the 0.00 indicator illustrates the P/E multiple dynamics for the company.
Summary analytical data breakdowns for CeriBell EEG (CBLL)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- debt burden and liquidity indicators:
- earnings and market ratios statistics:
CBLL - Net Financial Result|Expected Profit CeriBell, Inc.|CBLL - Price to Earnings Multiple|Forward P/E Multiple CeriBell Corp|CBLL - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio CeriBell Inc|CBLL - Operating income before deduction of amortization|Net earnings per share (EPS TTM) CeriBell|CBLL - Net earnings per share for the last 12 months|Quarterly EPS earnings growth ceribell.com|CBLL - Earnings per share growth in current year|Net earnings per share growth forecast for next year CeriBell, Inc.
General company analysis:CBLL CeriBell
Investors use this multiple to determine whether an asset is overbought relative to its future earnings. The metric is calculated as the ratio of the stock's market value to its projected annual profit. For CeriBell, Inc. (CBLL), this reflects the pace of organic adoption of diagnostic systems within clinics. Rising earnings expectations typically dampen volatility. When analyzing changes in the company's forward P/E, investors should avoid buying at valuation peaks.
Competing companies
Forward P/E Multiple BIIB|NBIX - Projected Price to Earnings Ratio|Future Price to Earnings Regencell RGC|Future Price to Earnings Multiple AXSM|ACADIA Pharmaceuticals - Forward P/E Multiple|Market Cap to Projected Earnings xenon-pharma.com XENE|VKTX: Forward P/E Multiple|SUPN (Supernus Pharmaceuticals, Inc.) - Future Price to Earnings|CPRX (Catalyst Pharmaceuticals Inc) - Forward P/E Multiple|Projected Price to Earnings Ratio Denali Corp DNLI|Future Price to Earnings Harmony Biosciences (HRMY)|Future Price to Earnings BHVN (biohavenpharma.com)|Future Price to Earnings Amylyx Pharmaceuticals, Inc. AMLX|Trevi Therapeutics Inc - Future Price to Earnings|PRAX: Projected Price to Earnings|Future Price to Earnings Multiple AVXL (Anavex Life Sciences Corp)|PRTA: Forward P/E Multiple|ALEC - Market Cap to Projected Earnings|Future Price to Earnings Annexon|Price to Future Earnings Ratio OMER (Omeros Corp.)|Forward P/E Multiple NGNE|Projected Price to Earnings AC Immune Inc ACIU|Voyager Therapeutics - Projected Price to Earnings|Market Cap to Projected Earnings neumoratx.com (NMRA)|Scilex - Forward P/E Multiple|Tevogen Bio Holdings Inc. (TVGN) - Projected Price to Earnings|ACOG: Forward P/E Multiple|CGTX (Cognition Therapeutics Inc.) - Future Price to Earnings|Future Price to Earnings Inhibikase Therapeutics|Future Price to Earnings SAVA|Future Price to Earnings Assertio Holdings, Inc. (ASRT)|Future Price to Earnings COYA (coyatherapeutics.com)|Future Price to Earnings Vistagen VTGN|OVID: Price to Future Earnings Ratio|Acumen Pharmaceuticals - Forward P/E Multiple|Projected Price to Earnings Ratio cervomed.com|ATHE (alteritytherapeutics.com) - Projected Price to Earnings|Clene (CLNN) - Forward P/E Multiple|Future Price to Earnings PepGen Inc|JUNS: Future Price to Earnings Multiple|Future Price to Earnings Relmada Therapeutics (RLMD)|ANVS - Projected Price to Earnings Ratio|Forward P/E Multiple GRCE (Grace Therapeutics)|AIFF - Projected Price to Earnings|ANEW Medical, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio NeuroSense Therapeutics|Reviva Pharmaceuticals (RVPH) - Future Price to Earnings|MetaVia - Future Price to Earnings Multiple|NRXS (NeurAxis) - Forward P/E Multiple|Helius Medical Technologies Inc. (HSDT) - Market Cap to Projected Earnings|Forward P/E Multiple PASG|Future Price to Earnings NEUP (bionomics.com.au)|Forward P/E Multiple NERV (Minerva Neurosciences)|athira.com (ATHA) - Projected Price to Earnings Ratio|ADXN - Future Price to Earnings|ALZN: Future Price to Earnings|cyclerion.com (CYCN) - Future Price to Earnings|PTIX (Protagenic Therapeutics, Inc.) - Future Price to Earnings|Projected Price to Earnings KTTA|CRGT: Future Price to Earnings Multiple|Forward P/E Multiple ATXI|Market Cap to Projected Earnings Brainstorm Cell Therapeutics Inc.|Future Price to Earnings Cara Therapeutics, Inc CARA|CHRO: Price to Future Earnings Ratio|Eliem - Forward P/E Multiple|Intra-Cellular Therapies (ITCI) - Projected Price to Earnings|LBPH (Longboard Pharmaceuticals, Inc.) - Projected Price to Earnings|MRNS - Market Cap to Projected Earnings|NKGN (NKGen) - Forward P/E Multiple|Projected Price to Earnings NeuroBo Pharma (NRBO)|Forward P/E Multiple SAGE|Future Price to Earnings SNPX (synaptogen.com)|Future Price to Earnings Trevena TRVN|Vigil Neuroscience Inc. - Future Price to Earnings|WENA - Future Price to Earnings|CERE: Future Price to Earnings
